These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21683309)

  • 21. Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.
    Sprakes MB; Hamlin PJ; Warren L; Greer D; Ford AC
    J Crohns Colitis; 2011 Aug; 5(4):324-31. PubMed ID: 21683302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease.
    Tanida S; Inoue N; Kobayashi K; Naganuma M; Hirai F; Iizuka B; Watanabe K; Mitsuyama K; Inoue T; Ishigatsubo Y; Suzuki Y; Nagahori M; Motoya S; Nakamura S; Arora V; Robinson AM; Thakkar RB; Hibi T
    Clin Gastroenterol Hepatol; 2015 May; 13(5):940-8.e3. PubMed ID: 25245624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful use of infliximab in a patient with neuro-Behçet's disease.
    Abalos-Medina GM; Sánchez-Cano D; Ruiz-Villaverde G; Ruiz-Villaverde R; Quirosa Flores S; Raya Alvarez E
    Int J Rheum Dis; 2009 Sep; 12(3):264-6. PubMed ID: 20374357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease.
    Aikawa NE; Gonçalves C; Silva CA; Gonçalves C; Bonfá E; de Carvalho JF
    Rheumatol Int; 2011 Aug; 31(8):1097-9. PubMed ID: 20012049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Hirano T; Ohguro N; Hohki S; Hagihara K; Shima Y; Narazaki M; Ogata A; Yoshizaki K; Kumanogoh A; Kishimoto T; Tanaka T
    Mod Rheumatol; 2012 Apr; 22(2):298-302. PubMed ID: 21748365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical efficacy of adalimumab for a postoperative marginal ulcer in gastrointestinal Behçet disease].
    Shimizu Y; Takeda T; Matsumoto R; Yoshida K; Nakajima J; Atarashi T; Yanagisawa H; Kikuchi K; Kikuchi H
    Nihon Shokakibyo Gakkai Zasshi; 2012 May; 109(5):774-80. PubMed ID: 22688103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adalimumab for the treatment of Behçet's disease: experience in 19 patients.
    Perra D; Alba MA; Callejas JL; Mesquida M; Ríos-Fernández R; Adán A; Ortego N; Cervera R; Espinosa G
    Rheumatology (Oxford); 2012 Oct; 51(10):1825-31. PubMed ID: 22723596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Treatment with Adalimumab for Intestinal Behcet's Disease during Pregnancy.
    Fujikawa K; Endo Y; Mizokami A; Takahashi K; Tabuchi M; Ohba K; Nakamura H; Kawakami A
    Intern Med; 2016; 55(10):1375-8. PubMed ID: 27181551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of adalimumab therapy for life-threatening pulmonary vasculitis in Behçet's disease.
    Aamar S; Peleg H; Leibowitz D; Chajek-Shaul T; Hiller N; Heyman SN
    Rheumatol Int; 2014 Jun; 34(6):857-60. PubMed ID: 23412691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of biologic agents in the treatment of ocular manifestations of Behcet's disease.
    Benitah NR; Sobrin L; Papaliodis GN
    Semin Ophthalmol; 2011; 26(4-5):295-303. PubMed ID: 21958178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic findings of gastrointestinal involvement in Chinese patients with Behcet's disease.
    Zou J; Shen Y; Ji DN; Zheng SB; Guan JL
    World J Gastroenterol; 2014 Dec; 20(45):17171-8. PubMed ID: 25493032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolution of Behçet's syndrome associated pulmonary arterial aneurysms with infliximab.
    Schreiber BE; Noor N; Juli CF; Haskard DO
    Semin Arthritis Rheum; 2011 Dec; 41(3):482-7. PubMed ID: 21546064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological agent in prevention of ocular recurrence in Behçets disease: a case report.
    Adnan IA; Kharelo SR; Biswas J
    Nepal J Ophthalmol; 2019 Jul; 11(22):218-222. PubMed ID: 32792699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adalimumab in the treatment of pediatric Behçet's disease: case-based review.
    Poddighe D; Mukusheva Z; Dauyey K; Assylbekova M
    Rheumatol Int; 2019 Jun; 39(6):1107-1112. PubMed ID: 30976833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Behcet's disease and recurrent aphthous ulcer according to characteristics of gastrointestinal symptoms.
    Rhee SH; Kim YB; Lee ES
    J Korean Med Sci; 2005 Dec; 20(6):971-6. PubMed ID: 16361807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Adalimumab in Behçet Disease Patients on Clinical Manifestations and on Pro-Inflammatory Cytokines Milieu: Long-Term Follow-Up.
    Braun-Moscovici Y; Tavor Y; Markovits D; Toledano K; Rozin A; Nahir MA; Balbir-Gurman A
    Isr Med Assoc J; 2020 May; 22(5):289-293. PubMed ID: 32378820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report.
    Lee SW; Lee SY; Kim KN; Jung JK; Chung WT
    Clin Rheumatol; 2010 Jan; 29(1):91-3. PubMed ID: 19816754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate sodium: effective treatment for therapy-refractory intestinal Behçet's disease, evaluated with enteroscopy.
    Kappen JH; Mensink PB; Lesterhuis W; Lachman S; van Daele PL; van Hagen PM; van Laar JA
    Am J Gastroenterol; 2008 Dec; 103(12):3213-4. PubMed ID: 19086980
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
    Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
    Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esophageal involvement in Behçet's syndrome.
    Anti M; Marra G; Rapaccini GL; Barone C; Manna R; Bochicchio GB; Fedeli G
    J Clin Gastroenterol; 1986 Oct; 8(5):514-9. PubMed ID: 3782747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.